> ## Content Index
> Fetch the complete content index at: https://med-techinsights.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FPT launches MediSight framework for AI-driven healthcare and life sciences innovation
- URL: https://med-techinsights.com/fpt-launches-medisight-framework-for-ai-driven-healthcare-and-life-sciences-innovation/
- Published: 2026-07-20T11:36:00.000Z
- Updated: 2026-10-22T08:04:52.000Z
- Description: FPT, a global technology and IT services provider headquartered in Vietnam, has announced the launch of MediSight, an AI-powered framework that it says is designed to help healthcare organisations, medical device manufacturers, and pharmaceutical organisations accelerate digital transformation, stre
- Author: Oliver Johnson
- Tags: Insights, Digital Health & AI, Artificial Intelligence

[**FPT**](https://fptsoftware.com/en?ref=med-techinsights.com), a global technology and IT services provider headquartered in Vietnam, has announced the launch of MediSight, an AI-powered framework that it says is designed to help healthcare organisations, medical device manufacturers, and pharmaceutical organisations accelerate digital transformation, strengthen regulatory compliance, and unlock actionable insights from healthcare data.

Built on FPT’s[ FleziPT](https://fptsoftware.com/flezipt?ref=med-techinsights.com) AI-first ecosystem and guided by[ CASAN](https://fptsoftware.com/newsroom/news-and-press-releases/news/fpt-introduces-casan-an-ai-transformation-framework-for-global-enterprises?ref=med-techinsights.com), FPT’s framework for progressing from AI experimentation to AI-native operations, the company says that MediSight enables healthcare and life sciences organisations to scale AI adoption across care delivery, business operations, and compliance functions, supporting faster innovation, stronger governance, and informed decision-making. 

The framework is structured around three core layers: firstly, the Healthcare Insight Platform, which the company says provides a cloud-native, interoperable data foundation; secondly, the MediSight Crew comprising of autonomous AI agents, digital workers, and healthcare-focused assistants; and MediSight Verse, which FPT says offers a portfolio of applications spanning clinical service management, claims administration, remote care, patient engagement, clinical trials, medical imaging, documentation, and healthcare analytics.

Mark Scrivens, CEO of FPT United Kingdom said: “The UK healthcare system has reached an important point in its adoption of AI where the focus is no longer simply to test new technologies, but to deploy them safely and at scale in ways that improve productivity, support overstretched workforces and ultimately deliver better care for patients. 

“For the NHS and its partners, that means connecting fragmented data, reducing time-consuming administrative processes and ensuring innovation can work alongside existing systems rather than adding further complexity. MediSight brings these capabilities together within a healthcare-focused framework while maintaining the security and governance required in highly regulated environments, helping connect fragmented data, reducing administrative burden and turning information into actionable insight to align with the NHS’s shift from analogue to digital.” 

Designed for healthcare security and governance requirements, MediSight supports industry requirements including GDPR compliance, HIPAA, HITRUST r2, and ISO 27001\. The framework is designed for deployment across major cloud environments and integration with established healthcare systems, allowing benefits to be adapted to the UK market. 

Mr. Chu Canh Chieu, FPT Software Vice President and Head of Healthcare and Life Sciences, FPT Corporation said: “The next phase of healthcare innovation demands systems that don’t just store data, but actively reason through it. MediSight helps healthcare organisations reduce manual effort, improve decision-making speed, and scale digital health solutions more efficiently. 

“By fusing autonomous AI agents with specialised clinical applications, we are helping digital health and pharma enterprises eliminate manual friction, reduce time-to-market for medical software, and elevate patient care and outcomes without compromising on strict regulatory standards.”